HealthEquity, Inc.

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: US42226A1079
USD
95.67
-3.21 (-3.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About HealthEquity, Inc. stock-summary
stock-summary
HealthEquity, Inc.
Capital Markets
HealthEquity, Inc. is a provider of a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. The Company's platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to help in their tax-advantaged healthcare savings.The Company's products and services include healthcare saving and spending platform, health savings accounts, investment platform and advisory services, reimbursement arrangements and HealthEquity retirement.
Company Coordinates stock-summary
Company Details
15 W Scenic Pointe Dr Ste 100 , DRAPER UT : 84020-6120
stock-summary
Tel: 1 801 72710001 801 7271209
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 135 Schemes (58.8%)

Foreign Institutions

Held by 177 Foreign Institutions (11.1%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Robert Selander
Independent Chairman of the Board
Mr. Jon Kessler
President, Chief Executive Officer, Director
DR. Stephen Neeleman
Vice Chairman of the Board, Founder
Mr. Frank Corvino
Independent Director
Mr. Adrian Dillon
Independent Director
Ms. Evelyn Dilsaver
Independent Director
Ms. Debra McCowan
Independent Director
Mr. Stuart Parker
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
326 Million
(Quarterly Results - Jul 2025)
Net Profit:
60 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 8,018 Million (Small Cap)

stock-summary
P/E

53.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

9.56%

stock-summary
Price to Book

3.74